BMY Bristol-Myers Squibb beats by $0.03, beats on revenue Bristol-Myers Squibb (NYSE:BMY): Q3 EPS of $0.45 beats by $0.03. Revenue of $3.92B (-3.4% Y/Y) beats by $120M. Shares +0.19% PM.